Hand Eczema in US Workers’ Compensation: 226 Closed Claims Across 15 Years
Doctor’s Notes · Life in Motion · Evidence Review
Editorial disclosure: The featured scene is an AI-created illustration of fictional people and work settings, not a patient, diagnosis, before-and-after image or Dr. Arsy #003 result.
The practical question
The large gap between means and medians shows that a small number of prolonged costly claims can dominate averages.
The study is most useful when its population, design, denominator and timepoint stay attached. A percentage from a clinic, registry, survey or prevention program is not an individual prediction and cannot diagnose the cause of a rash.
Study snapshot
| Study element | Reported detail |
|---|---|
| Population | 226 closed hand-eczema-related workers’ compensation claims from more than 500 self-insured US employers |
| Design | Retrospective administrative-claims analysis |
| Timepoint | 2010–2024 |
| Key result | Claims averaged 343 open days (median 121) and $10,197 (median $477); 26 lost-time claims averaged 277 days (median 51) |
Reading the result carefully
Claims averaged 343 open days (median 121) and $10,197 (median $477); 26 lost-time claims averaged 277 days (median 51).
Coding may miss cases, closed claims are not all workers with hand eczema, dollar amounts depend on benefits and litigation, and claim data lack detailed clinical severity.
That distinction matters. A correlation can identify a pattern without proving cause. A before-and-after program can show change without showing which component produced it. A mean can also conceal a smaller group with persistent severe disease, very high cost or prolonged absence.
What this can mean at work
Report medians and means together, and build early exposure control and work accommodation before a claim becomes prolonged.
A useful occupational history identifies the exact task, material, frequency, wet-work time, glove type, cleaning method, symptom timing and functional effect. Prevention follows a hierarchy: eliminate or substitute hazards where feasible, control the process, train the worker, and then use correctly selected protective equipment. Moisturizer can support dry-skin comfort; it cannot neutralize a hazardous exposure.
Questions to bring to care
- Which diagnosis and exposure hypothesis best fit the timing and distribution?
- Is clinician-directed patch testing or occupational review appropriate?
- What concrete outcome will be tracked: severity, sleep, function, absence, productivity or job retention?
- What would trigger urgent evaluation, such as rapidly spreading redness, drainage, fever, severe pain or major functional loss?
Primary and authoritative sources
- Primary medical research record: PubMed PMID 41984619
- NIAMS: atopic dermatitis overview
- American Academy of Dermatology: skin-care guidance
- NIOSH: occupational skin-exposure recommendations
PubMed indexing is not NIH endorsement of a study’s interpretation, this article or any product.
Where a cosmetic moisturizer fits
Dr. Arsy #003 is a cosmetic moisturizer for hydration, moisture-barrier support and dry-skin comfort. This study did not test #003, and external results do not become product results. #003 is not an eczema medicine and this article makes no treatment, cure, prevention, pediatric-safety or 24-hour claim.
Bottom line
The responsible conclusion is the narrow one: preserve the denominator, comparator, timepoint and limitations, then use the study to ask better clinical and workplace questions rather than to promise a universal result.
Educational content only. Researchers and cited organizations do not endorse Dr. Arsy.